Systemic sclerosis is associated with a high level of patient mortality. A promising prognostic model that could enable more effective management and improve survival was recently validated; however, the results demonstrate that choosing the best cohorts for development and validation of predictors of mortality is essential.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Steen, V. D. & Medsger, T. A. Changes in causes of death in systemic sclerosis, 1972–2002. Ann. Rheum. Dis. 66, 940–944 (2007).
Al-Dhaher, F. F., Pope, J. E. & Ouimet, J. M. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin. Arthritis Rheum. 39, 269–277 (2010).
Nihtyanova, S. et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 103, 109–115 (2010).
Fransen, J. et al. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann. Rheum. Dis. 70, 1788–1792 (2011).
Bryan, C., Howard, Y., Brennan, P., Black, C. & Silman, A. Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. Br. J. Rheumatol. 35, 1122–1126 (1996).
Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847 (1998).
Wasson, J. H., Sox, H. C., Neff, R. K. & Goldman, L. Clinical prediction rules. Applications and methodological standards. N. Engl. J. Med. 313, 793–799 (1985).
Laupacis, A., Sekar, N. & Stiell, I. G. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277, 488–494 (1997).
Toll, D. B., Janssen, K. J., Vergouwe, Y. & Moons, K. G. Validation, updating and impact of clinical prediction rules: a review. J. Clin. Epidemiol. 61, 1085–1094 (2008).
Altman, D. G. & Royston, P. What do we mean by validating a prognostic model? Stat. Med. 19, 453–473 (2000).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Domsic, R., Medsger, T. Predicting death in SSc: planning and cooperation are needed. Nat Rev Rheumatol 7, 628–630 (2011). https://doi.org/10.1038/nrrheum.2011.152
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2011.152
This article is cited by
-
Does ex vi vo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?
Bone Marrow Transplantation (2016)
-
Autologe Stammzelltransplantation bei systemischer Sklerose
Zeitschrift für Rheumatologie (2016)